MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$85,854K
EPS
-$1.14
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
67,301
60,819
49,889*
54,178
General and administrative
24,342
21,953
19,040*
17,100
Merger transaction costs
4,361
-
-
-
Total operating expenses
96,004
82,772
68,929
71,278
Loss from operations
-96,004
-82,772
-68,929*
-71,278
Interest income, net
11,808
8,740
9,842
6,318
Interest expense
1,580
-
-
-
Total other income, net
10,228
8,740
9,842*
6,318
Net loss before taxes
-85,776
-74,032
-59,088*
-64,960
Provision for income taxes
78
79
79*
61
Net loss after taxes
-85,854
-74,111
-59,167
-65,021
Basic EPS
-1.14
-1.06
-0.912
-1.11
Diluted EPS
-1.14
-1.06
-0.912
-1.11
Basic Average Shares
75,443,496
69,668,439
64,870,385
58,773,731
Diluted Average Shares
75,443,496
69,668,439
64,870,385
58,773,731
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss after taxes
-$85,854K
(-29.89%↓ Y/Y)
Interest income, net
$11,808K
(65.35%↑ Y/Y)
Net loss before
taxes
-$85,776K
(-29.92%↓ Y/Y)
Provision for income taxes
$78K
(8.33%↑ Y/Y)
Total other income,
net
$10,228K
(43.23%↑ Y/Y)
Interest expense
$1,580K
Loss from operations
-$96,004K
(-31.22%↓ Y/Y)
Total operating
expenses
$96,004K
(31.22%↑ Y/Y)
Research and development
$67,301K
(20.82%↑ Y/Y)
General and
administrative
$24,342K
(39.40%↑ Y/Y)
Merger transaction
costs
$4,361K
Buy us a coffee
Apogee Therapeutics, Inc. (APGE)
Apogee Therapeutics, Inc. (APGE)